Treatment of normotensive glaucoma with angiotensin II antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5889020
SERIAL NO

08682772

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of angiotensin antagonist or a pharmaceutically acceptable salt thereof for the treatment of normal tension glaucoma, wherein said angiotensin antagonist and salt thereof have pronunced selectivity for the AT1 receptor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS CORPORATION608 FIFTH AVENUE NEW YORK NY 10020

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Huxley, Alica Binningen, CH 4 65
Mathis, Georg Bulach, CH 1 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation